PanCanSurvPlot

PanCanSurvPlot is a large-scale interactive web tool dedicated to pan-cancer transcriptome survival analysis and visualization. With PanCanSurvPlot, users can quickly explore the impact of target genes on survival outcomes in different tumors, assisting clinicians and researchers in further investigating the mechanism of tumor development and improving clinical decision-making.

PanCanSurvPlot is accessible at: http://www.PanCanSurvPlot.com/(New) and https://smuonco.shinyapps.io/PanCanSurvPlot/.

The preprint is now online.

Citation: Lin, A., Yang, H., Shi, Y., Cheng, Q., Liu, Z., Zhang, J., & Luo, P. (2022). PanCanSurvPlot: A Large-scale Pan-cancer Survival Analysis Web Application. BioRxiv, 2022.12.25.521884. https://doi.org/10.1101/2022.12.25.521884.


Something went wrong...Please refresh page.

How does PanCanSurvPlot work?


STEP1: Select Data to Be Processed

STEP2: View Analysis Results

STEP3: Costomize and Download Your Plot



Tutorial

Learn more about PanCanSurvPlot on the Youtube tutorial video. For users who can not access YouTube, the tutorial video is also available on Bilibili.

Updates

19/01/23 Version 1.2.1 released. Cox results (continuous) are now available.

29/12/22 Version 1.2.0 released. Therapy Details are now available.

25/11/22 Version 1.1.0 released. TCGA data are now available.

23/10/22 Version 1.0.0 released.


STEP1: Select Data to Be Processed

STEP2: View Analysis Results

Loading...

STEP3: View, Costomize and Download Your Plot


Loading...

DATASETS DESCRIPTION

Loading...

Contact

Should you have any questions, please feel free to contact us.

Peng Luo: luopeng@smu.edu.cn

Hong Yang: smuyanghong@i.smu.edu.cn

Ying Shi: shoshanashi@i.smu.edu.cn


Our lab has a long-standing interest in cancer biomedical research and bioinformatics. We recently developed several other Shiny web tools focusing on solving various scientific questions.

CAMOIP: A Web Server for Comprehensive Analysis on Multi-omics of Immunotherapy in Pan-cancer. doi: 10.1093/bib/bbac129

Onlinemeta: A Web Server For Meta-Analysis Based On R-shiny. doi: 10.1101/2022.04.13.488126[preprint]

Tutorial Video

For users who can not access YouTube, the tutorial video is also available on Bilibili.

Comment Box

Update History

19/01/23 Version 1.2.1 of PanCanSurvPlot released.
NEW FEATURE: Cox results (continuous) have been added to the results summary table.

29/12/22 Version 1.2.0 of PanCanSurvPlot released.
NEW FEATURE: Therapy Details are now available. The preprint is now online.

25/11/22 Version 1.1.0 of PanCanSurvPlot released.
NEW FEATURE: TCGA data are now available. Bugs of sorting the scientific notation were repaired.

23/10/22 Version 1.0.0 of PanCanSurvPlot released.

08/10/22 Version 1.0.0beta of PanCanSurvPlot released.

FAQ

1. Why does the gene symbol I type in return no results?

The gene symbols we provided here mostly come from HGNC-approved protein-coding genes, noncoding RNA genes and pseudogenes. The whole list of genes we provided can be found here.

2. What are the full forms of the survival outcomes provided?

Altogether, there are 13 different survival outcomes available. Their abbreviations and corresponding full forms are shown below.

BCR: Biochemical Recurrence Free Survival

CSS: Cancer Specific Survival

DFI: Disease Free Interval

DFS: Disease Free Survival

DMFS: Distant Metastasis Free Survival

DRFS: Distant Relapse Free Survival

DSS: Disease Specific Survival

FFS: Failure Free Survival

MFS: Metastasis Free Survival

OS: Overall Survival

PFI: Progression Free Interval

PFS: Progression Free Survival

RFS: Recurrence Free Survival

3. Why is there no median survival line shown in the K-M plot I have made?

Because of the specific cutoff point you chose, the median survival has not yet been reached, and more than half of the patients are still alive.

4. What is the difference between COX results (continuous) and COX results with the median/best cutpoint? How are they calculated?

For COX results (continuous), we treated the patient survival data as a continuous variable and fitted a Cox proportional hazards regression model to them. For COX results with the median/best cutpoint, we grouped the patient survival data according to the median/best cutpoint and performed the bivariate Cox proportional hazards regression.

5. Why does the p-value and confidence interval of the hazard ratio disagree, with the p-value < 0.05 but the 95% confidence interval of the hazard ratio covers 1.0 or vice versa?

Due to reasons such as small sample sizes or uneven groupings in some of the datasets, the high level of sampling error might cause the inconsistency between p value and 95% confidence interval.